LifeScience

Waters Launches OligoWorks™ SPE Workflow and Kits for Faster Oligonucleotide Bioanalysis

Delivers up to 2x[i] higher oligonucleotide recovery from biofluids with improved LC-MS sensitivity and reproducibility to support robust quantitati...

 October 23, 2023 | News

SOPHiA GENETICS Partners with MSKCC and AstraZeneca for Global Cancer Care Equality

SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in data-driven medicine today announced a collaboration with&...

 October 19, 2023 | News

Thermo Fisher Scientific Acquires Next-Gen Proteomics Leader Olink

Enhances Thermo Fisher’s Capabilities in the High-Growth Proteomics Market with the Addition of Highly Differentiated Solutions Complements Existing...

 October 18, 2023 | News

Ascentage Pharma & AstraZeneca Collaborate on Phase III Study for CLL/SLL Treatment

The two companies will jointly conduct a registrational Phase III study of the Bcl-2 inhibitor, APG-2575 (lisaftoclax), in combination with AstraZeneca's B...

 October 16, 2023 | News

ABL Bio Achieves Regulatory Clearance for Innovative Bispecific Antibody in Solid Tumor; GenScript ProBio Commends Milestone Collaboration

ABL103 is a novel T-cell engaging bispecific antibody and demonstrates efficacious anti-tumor activity via B7-H4 mediated 4-1BB activation in tumor mi...

 October 13, 2023 | News

Discovery Life Sciences Reveals Major Expansions: New Facilities, Tech, and Global Brand Upgrades

With support from the State of Alabama and HudsonAlpha, Discovery has opened its new 93,000-square-foot global headquarters building in ...

 October 13, 2023 | News

MediLink and BioNTech Partner for Advanced Anti-Cancer Drug

Under the terms of the agreement, MediLink will grant BioNTech exclusive global rights for the development, manufacturing, and commercialization of one of ...

 October 13, 2023 | News

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value R...

 October 10, 2023 | News

Agilent & Sarawak Infectious Disease Centre to Enhance Tropical Disease Research in East Malaysia

Neglected tropical diseases (NTDs) are a diverse group of 20 conditions that are mainly prevalent in tropical areas, where they primarily affect impov...

 October 09, 2023 | News

Merck Launches New Collaboration with United Nations-Guided Global Initiative on Ageing to Support Carers

Merck, a leading science and technology company,  announced a new collaboration with the United Nations-Guided Global Initiative on Ageing (GIA) to pr...

 October 06, 2023 | News

Novavax COVID-19 Vaccine Authorized and Recommended in U.S. for 2023-2024

This Emergency Use Authorization and CDC recommendation makes Novavax's vaccine the only protein-based non-mRNA COVID vaccine option in the U.S. No...

 October 04, 2023 | News

Bausch + Lomb Completes Acquisition of XIIDRA®

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better,  announced it h...

 October 02, 2023 | News

PHC and JCR Pharma Release Second Update for "Meron Diary" Growth Hormone Treatment App

Jointly developed by PHC IVD and JCR Pharma and released for the first time in October 2020, "Meron Diary" is a smartphone application that can wirelessly ...

 October 02, 2023 | News

Sartorius Forms Partnership with SPARTA Biodiscovery on Novel Nanoparticle Analysis Platform

SPARTA technology to accelerate the development, manufacture and quality control of nanoparticles used for gene therapies, vaccines, and cancer drugs Sa...

 September 29, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close